https://doi.org/10.4081/monaldi.2022.2276
Cardiac biomarkers and mortality in COVID-19 infection: A review
Submitted: March 27, 2022
Accepted: June 16, 2022
Published: June 23, 2022
Accepted: June 16, 2022
Abstract Views: 1209
PDF: 381
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Lots of meta-analysis emphasize that a great number of hospitalized patients with moderate and severe forms of COVID-19 developed acute myocardial damage, defined as an increase of cardiac biomarkers, such N-terminal pro–B-type natriuretic peptide (NT-pro-BNP), creatine kinase-myocardial band (CK-MB) and of all type of troponins. The highest mortality rate is related with progressively increasing biomarkers levels and with a history of cardiovascular disease. In fact, the biomarkers dosage should be considered as a prognostic marker in all patients with COVID-19 disease at admission, during hospitalization and in the case of clinical deterioration. The purpose of this review is to evaluate cardiovascular prognostic factors in COVID-19 disease throughout the analysis of cardiac biomarkers to early identify the most serious patients and to optimize their outcomes.
Su S, Wong G, Shi W, et al. Epidemiology, Genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490-502.
DOI: https://doi.org/10.1016/j.tim.2016.03.003
World Health Organization. Coronavirus disease 2019 (COVID-19), Situation Report 32. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200221-sitrep-32-covid-19.pdf?sfvrsn=4802d089_2
Aboughdir M, Kirwin T, Khader AA, et al. Prognostic value of cardiovascular biomarkers in COVID-19: A review. Viruses 2020;12:527.
DOI: https://doi.org/10.3390/v12050527
Danwang C, Endomba FT, Nkeck JR, et al. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res 2020;8:37.
DOI: https://doi.org/10.1186/s40364-020-00217-0
Nguyen JL, Yang W, Ito K, et al. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol 2016;1:274-81.
DOI: https://doi.org/10.1001/jamacardio.2016.0433
Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 2011;8:e1001048.
DOI: https://doi.org/10.1371/journal.pmed.1001048
Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann Saudi Med 2016;36.78.
DOI: https://doi.org/10.5144/0256-4947.2016.78
Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811-8. Erratum in: JAMA Cardi. 2020;5:848.
DOI: https://doi.org/10.1001/jamacardio.2020.1017
Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020 26;368:m1091. Erratum in: BMJ 2020;368:m1295.
DOI: https://doi.org/10.1136/bmj.m1091
Yang C, Liu F, Liu W, et al. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol 2021;326:230-6.
DOI: https://doi.org/10.1016/j.ijcard.2020.09.048
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-1062.. Erratum in: Lancet 2020;395:1038.
DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
Han H, Xie L, Liu R, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol 2020;92:819-23.
DOI: https://doi.org/10.1002/jmv.25809
Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 2020;41:1821-9. Erratum in: Eur Heart J 2020;41:4591.
DOI: https://doi.org/10.1093/eurheartj/ehaa388
Lombardi CM, Carubelli V, Iorio A, et al. Association of troponin levels with mortality in italian patients hospitalized with coronavirus disease 2019: Results of a multicenter study. JAMA Cardiol 2020;5:1274-80.
DOI: https://doi.org/10.1001/jamacardio.2020.3538
Stefanini GG, Chiarito M, Ferrante G, et al. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart 2020;106:1512-8.
DOI: https://doi.org/10.1136/heartjnl-2020-317322
Poterucha TJ, Elias P, Jain SS, et al. Admission cardiac diagnostic testing with electrocardiography and troponin measurement prognosticates increased 30-day mortality in COVID-19. J Am Heart Assoc 2021;10:e018476.
DOI: https://doi.org/10.1161/JAHA.120.018476
Aggarwal S, Garcia-Telles N, Aggarwal G, et al. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl) 2020;7:91-6.
DOI: https://doi.org/10.1515/dx-2020-0046
Nathisuwan S, Talbert RL. A review of vasopeptidase inhibitors: A new modality in the treatment of hypertension and chronic heart failure. Pharmacotherapy 2002;22:27-42.
DOI: https://doi.org/10.1592/phco.22.1.27.33502
Levin ER, Frank HJL. Natriuretic peptides inhibit rat astroglial proliferation: Mediation by C receptor. Am J Physiol 1991;261:R453-7.
DOI: https://doi.org/10.1152/ajpregu.1991.261.2.R453
Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation 1996;94:3184-9.
DOI: https://doi.org/10.1161/01.CIR.94.12.3184
Omland T. Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia. Scand J Clin Lab Invest Suppl 2005;240:18-24.
DOI: https://doi.org/10.1080/00365510500236077
Caro-Codón J, Rey JR, Buño A, et al. Characterization of NT-proBNP in a large cohort of COVID-19 patients. Eur J Heart Fail 2021;23:456-64.
DOI: https://doi.org/10.1002/ejhf.2095
Sorrentino S, Cacia M, Leo I, et al. B-type natriuretic peptide as biomarker of COVID-19 disease severity-A meta-analysis. J Clin Med 2020;9:2957.
DOI: https://doi.org/10.3390/jcm9092957
Gao L, Jiang D, Wen XS, et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res 2020;21:83.
DOI: https://doi.org/10.1186/s12931-020-01352-w
Park DW, Kim YH, Yun SC, et al. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. Eur Heart J 2013;34:1662-9.
DOI: https://doi.org/10.1093/eurheartj/eht048
Bao J, Li C, Zhang K, et al. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta 2020;509:180-94.
DOI: https://doi.org/10.1016/j.cca.2020.06.009
Shi L, Wang Y, Wang Y, et al. Meta-analysis of relation of creatine kinase-MB to risk of mortality in coronavirus disease 2019 patients. Am J Cardiol 2020;130:163-5.
DOI: https://doi.org/10.1016/j.amjcard.2020.06.004
Babapoor-Farrokhran S, Gill D, Walker J, et al. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020;253:117723.
DOI: https://doi.org/10.1016/j.lfs.2020.117723
Boukhris M, Hillani A, Moroni F, et al. Cardiovascular implications of the COVID-19 pandemic: A global perspective. Can J Cardiol 2020;36:1068-80.
DOI: https://doi.org/10.1016/j.cjca.2020.05.018
Li JW, Han TW, Woodward M, et al. The impact of 2019 novel coronavirus on heart injury: A systematic review and meta-analysis. Prog Cardiovasc Dis 2020;63:518-24.
DOI: https://doi.org/10.1016/j.pcad.2020.04.008
Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802-10.
DOI: https://doi.org/10.1001/jamacardio.2020.0950
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9. Erratum in: JAMA 2021;325:1113.
DOI: https://doi.org/10.1001/jama.2020.1585
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2. Erratum in: Lancet Respir Med 2020;8:420-2.
DOI: https://doi.org/10.1016/S2213-2600(20)30076-X
Bonow RO, Fonarow GC, O’Gara PT, et al. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol 2020;5:751-3.
DOI: https://doi.org/10.1001/jamacardio.2020.1105
Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018;378:345-53.
DOI: https://doi.org/10.1056/NEJMoa1702090
Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007;28:1205-10.
DOI: https://doi.org/10.1093/eurheartj/ehm035
Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:819-24.
DOI: https://doi.org/10.1001/jamacardio.2020.1096
Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med 2020;383:2255-73.
DOI: https://doi.org/10.1056/NEJMra2026131
Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis 2020;63:390-1.
DOI: https://doi.org/10.1016/j.pcad.2020.03.001
Pranata R, Huang I, Lukito AA, et al. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: Systematic review and meta-analysis. Postgrad Med J 2020;96:387-91.
DOI: https://doi.org/10.1136/postgradmedj-2020-137884
Dalia T, Lahan S, Ranka S, et al. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis. Indian Heart J 2021;73:91-8.
DOI: https://doi.org/10.1016/j.ihj.2020.12.002
Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol 2020;92:797-806.
DOI: https://doi.org/10.1002/jmv.25783
Liu C, Wang Y. [Discussion on the application of febrile disease theory to the diagnosis and treatment of novel coronavirus pneumonia].[Article in Chinese with English Abstract]. Lanzhou University 2020. Available from: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/czh-842?lang=en
Wei JF, Huang FY, Xiong TY, et al. Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis. Heart 2020;106:1154-9.
DOI: https://doi.org/10.1136/heartjnl-2020-317007
Ghio S, Baldi E, Vicentini A, et al. Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy. Intern Emerg Med 2020;15:1457-65. Erratum in: Intern Emerg Med 2021;16:807.
DOI: https://doi.org/10.1007/s11739-020-02604-9
How to Cite
Cersosimo, Angelica, Giuliana Cimino, Ludovica Amore, Emiliano Calvi, Greta Pascariello, Riccardo Maria Inciardi, Carlo Mario Lombardi, Enrico Vizzardi, and Marco Metra. 2022. “Cardiac Biomarkers and Mortality in COVID-19 Infection: A Review”. Monaldi Archives for Chest Disease 93 (1). https://doi.org/10.4081/monaldi.2022.2276.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Salvatore De Rosa, Mario Pacileo, Laura Sasso, Vito Di Palma, Paola Maietta, Antonella Paglia, Linda Brevetti, Plinio Cirillo, Massimo Chiariello, Insights into pathophysiology of smoke-related cardiovascular disease , Monaldi Archives for Chest Disease: Vol. 70 No. 2 (2008): Cardiac series
- Giuseppe Francavilla, Maurizio Giuseppe Abrignani, Annabella Braschi, Rosalba Sciacca, Vincenzo Christian Francavilla, Marco Malvezzi Caracciolo, Nicola Renda, Carmine Riccio, Anna Scaglione, Giambattista Braschi, Physical exercise and Sport activities in patients with and without coronary heart disease , Monaldi Archives for Chest Disease: Vol. 68 No. 2 (2007): Cardiac series
- Francesco Giallauria, Teresa Paragliola, Francesco Pilerci, Domenico Del Forno, Anna De Lorenzo, Athanasio Manakos, Rosa Lucci, Marianna Psaroudaki, Mariantonietta D’Agostino, Carlo Vigorito, Role of smokers in the household and of cardiac rehabilitation in smoking behaviour after acute myocardial infarction , Monaldi Archives for Chest Disease: Vol. 64 No. 2 (2005): Cardiac series
- Gaetano Gentile, Ester Meles, Claudio Carbone, Edoardo Cantù, Stefano Maggiolini, Unusual case of myocardial injury induced by Escherichia coli sepsis , Monaldi Archives for Chest Disease: Vol. 74 No. 1 (2010): Cardiac series
- Lucrezia Piccioli, Michele Arcopinto, Andrea Salzano, Roberta D'Assante, Alessandra Schiavo, Francesca M. Stagnaro, Anna Lombardi, Veronica Panicara, Pietro Valente, Giuseppe Vitale, Filippo M. Sarullo, Francesco Giallauria, Alberto M. Marra, The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Katia Rinero, Marzia Testa, Paola Vallauri, Sonia Garnero, Mauro Feola, Evaluating short term efficacy of educative support in a cardiovascular rehabilitation using the MICRO-Q test: a single centre experience , Monaldi Archives for Chest Disease: Vol. 80 No. 2 (2013): Cardiac series
- Paolo Ruggeri, Federica Lo Bello, Francesco Nucera, Michele Gaeta, Francesco Monaco, Gaetano Caramori, Giuseppe Girbino, Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report , Monaldi Archives for Chest Disease: Vol. 87 No. 3 (2017)
- Stefania Paolillo, Giuseppe Luca Della Ratta, Alice Vitagliano, Annapaola Cirillo, Elisabetta Lardino, Tiziana Formisano, Irma Fabiani, Angela Maria Pellegrino, Pietro Riello, Pasquale Perrone Filardi, New perspectives in cardiovascular risk reduction: focus on HDL , Monaldi Archives for Chest Disease: Vol. 80 No. 1 (2013): Cardiac series
- Eduardo Bossone, Giuseppe Limongelli, Graziella Malizia, Francesco Ferrara, Olga Vriz, Rodolfo Citro, Alberto Maria Marra, Michele Arcopinto, Emanuele Bobbio, Domenico Sirico, Luigi Caliendo, Andrea Ballotta, Antonello D’Andrea, Alessandro Frigiola, Jorgen Isgaard, Luigi Saccà , Antonio Cittadini, The T.O.S.CA. Project: Research, Education and Care , Monaldi Archives for Chest Disease: Vol. 76 No. 4 (2011): Cardiac series
- Niccolò Marchionni, Francesco Orso, Cholesterol: until which age 'the lower the better'? , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
